Skip to main content
Log in

Comparison of ceftibuten vs. amoxicillin/clavulanic acid as antibiotic prophylaxis in cholecystectomy and/or biliary tract surgery

  • Published:
Journal of Gastrointestinal Surgery

Abstract

A randomized, comparative, prospective clinical trial was carried out at a tertiary care center to compare the efficacy of two antibiotic regimens in the prophylaxis of postoperative infection in patients undergoing biliary tract surgery. One hundred patients undergoing cholecystectomy or biliary tract exploration were randomly allocated to one of the following antibiotic regimens: the standard regimen of three doses of amoxicillin/clavulanic acid (1000/200 mg) given by intravenous infusion, or a single dose of ceftibuten (400 mg) given orally. Patients were monitored during their stay in the hospital and over a 2 week period as outpatients. Fifty adult patients were included in each group. Mean age was 49 years, and sex distribution was 82 women and 18 men. The groups were comparable in terms of demographic characteristics and comorbidity. There were no cases of postoperative infection in the ceftibuten group, but five cases of infection occurred in the amoxicillin/clavulanic acid group (P <0.05). No adverse effects were observed with either antibiotic. The treatment cost per patient was significantly lower for ceftibuten. The results indicate that ceftibuten is well tolerated and more effective than amoxicillin/clavulanic acid for prophylaxis following gallbladder and biliary tract surgery. In addition, ceftibuten has the advantage of being more cost-effective and easier to administer than amoxicillin/clavulanic acid so it could be considered as an alternative for antibiotic prophylaxis in these types of surgical procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bordon DW. Principles of antimicrobial prophylaxis. WorldJ Surg 1982;6:262–267.

    Article  Google Scholar 

  2. Plat R. Antibiotic prophylaxis in surgery. Rev Infect Dis 1984;6:1880–1886.

    Google Scholar 

  3. Orozco H, Sifuentes J, Prado E, Takahashi T, López-Graniel CM, Anaya F., Canto J. [Comparison of two antimicrobial prophylaxis regimens in biliary tract surgery: A randomized controlled clinical trial. Rev Invest Clin 1993;45:565–569 (in Spanish).

    PubMed  CAS  Google Scholar 

  4. Wise R. The pharmacokinetics of the oral cephalosporins—A review. J Amtimicrob Chemother 1990;26(Suppl E):13–20.

    CAS  Google Scholar 

  5. Fassbender M, Lode H, Schaberg T, Borner K, Koeppe P. Pharmacokinetics of new oral cephalosporins, including a new carbacephem. Clin Infect Dis 1993;16:646–653.

    PubMed  CAS  Google Scholar 

  6. Lode H, Fassbender M, Schaberg T, Borner K, Koeppe P. Comparative pharmacokinetics of the new oral cephalosporins. Drags 1994;47(Suppl 3):10–19.

    CAS  Google Scholar 

  7. Kearns GL, Young RA. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on pediatrie use. Clin Pharma- cokinet 1994;26:169–189.

    CAS  Google Scholar 

  8. Rosenfeld RM, Doyle WJ, Swarts JD, SerokyJ, Greene I. Ef- ficacy of ceftibuten for acute otitis media caused by Haemophilus influenzae: An animal study. Ann Otol Rhinol Laryngol 1993;l02:222–226.

    Google Scholar 

  9. Chin NX, Gu JW, Nen HC. Antimicrobial effects of the com- bination of ceftibuten and an orally absorbed penem SCH 29482. Diagn Microbiol Infect Dis 1991;14:79–83.

    Article  PubMed  CAS  Google Scholar 

  10. Barr WH, Lin CC, Radwansld E, Lim J, Symchowicz, S, Af-frime M. The pharmacokinetics of ceftibuten in humans. Di- agn Microbiol Infect Dis 1991;14:93–100.

    Article  CAS  Google Scholar 

  11. Baurnfeind A, Jungwrith R. Antibacterial activity cefpodoxime in comparison with cefixime, cemidir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and ce- fradroxil. Infection 1991;19:353–362.

    Article  Google Scholar 

  12. Jones RN. Antimicrobial activity and spectrum of ceftibuten (7432-S, SHC 39720). A review of United States and Canada results. Diagn Microbiol Infect Dis 1991;14:37–43.

    Article  PubMed  CAS  Google Scholar 

  13. Debbia EA, Pesce A, Chiesa M, Ricotta N, Schito GC. Mi- crobiologie profile of ceftibuten, a new oral cephalosporin. Drugs Exp Clin Res 1992;18:129–139.

    PubMed  CAS  Google Scholar 

  14. Soussy CJ, Meyran M, Chanal M, Reverdy ME, Kitzis MD, Derlot E. In vitro antibacterial activity of a new oral cepha- losporin, ceftibuten. Results of a multicentric study. Pathol Biol 1991;39:396–402.

    PubMed  CAS  Google Scholar 

  15. Prado D, Lopez E, Liu H, Devoto S, Woloj M, Contrini M, Murray BE, Gomez H, Cleary T. Ceftibuten and trimetho- prim/sulfamethoxazole for treatment of Shigella and en- teroinvasive Escherichia coli disease. Pediatr Infect Dis J 1992;11:644–647.

    PubMed  CAS  Google Scholar 

  16. Gorbach SL, Condon RE, Conte JE Jr, Kaiser AB, Ledger WJ, Lee-Nichols R. Evaluation of new anti-infective drags for surgical prophylaxis. Infectious Disease Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15(Sl):313–338.

    Google Scholar 

  17. Zar JH. Biostatistical Analysis, 2nd ed. New York: Prentice Hall, 1984.

    Google Scholar 

  18. Chetlin SH, Elliot DW. Preoperative antibiotics in biliary sur- gery. Arch Surg 1973;107:319–323.

    PubMed  CAS  Google Scholar 

  19. Keighley MRB, Baddeley RM, Burdon DW. A controlled trial of parenteral prophylactic therapy in biliary surgery. Br J Surg 1975;62:275–279.

    Article  PubMed  CAS  Google Scholar 

  20. Griffiths DA, Shorey BA, Simpson RA. Single-dose preoper- ative antibiotic prophylaxis in gastrointestinal surgery. Lancet 1976;2:325–328.

    Article  PubMed  CAS  Google Scholar 

  21. Waddell TK, Rotstein OD. Antimicrobial prophylaxis in sur- gery. Committee on antimicrobial agents, Canadian Infectious Disease Society. Can Med AssocJ 1995;152:1381–1382.

    Google Scholar 

  22. McArdle CS, Morran CG, Pettit L, Gemmell CG, Sleigh JD, Tillotson GS. Value of oral antibiotic prophylaxis in colorec- tal surgery. Br J Surg 1995;82:1046–1048.

    Article  PubMed  CAS  Google Scholar 

  23. Nungu KS, Olerud C, Rehnberg L, Larsson S, Nordell P, Al-lvin I, Bengtsson S, Wallinder L, Hedin G. Prophylaxis with oral ccfadroxil versus intravenous cefuroxime in trochanteric fracture surgery. A clinical multicentre study. Arch Orthop Trauma Surg 1995;114:303–307.

    Article  PubMed  CAS  Google Scholar 

  24. McArdle CS, Morran CG, Anderson JR, Pettit L, Gemmell CG, Sleigh JD, Tillotson GS. Oral ciprofloxacin as prophylaxis in gastroduodenal surgery. J Hosp Infect 1995;30:211–216.

    Article  PubMed  CAS  Google Scholar 

  25. Risberg B, Drott C, Dalman P, Holm J, Ivarsson L, Jivegard L, Karlstrom L, Oden A, Pedersen P, Rahm V, et al.. Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: Random- ized double-blind, prospective multicentre study. Eur J Vase Endovasc Surg 1995;10:346–351.

    Article  CAS  Google Scholar 

  26. Botto H, Butreau-Lamaire M, Levy S, Deval C. [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic pro- phylaxis in transurethral prostate resection]. Prog Urol 1993; 3:569–575 (in French).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by Schering-Plough de México.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Orozco, H., Sifuentes-Osomio, J., Chan, C. et al. Comparison of ceftibuten vs. amoxicillin/clavulanic acid as antibiotic prophylaxis in cholecystectomy and/or biliary tract surgery. J Gastrointest Surg 4, 606–610 (2000). https://doi.org/10.1016/S1091-255X(00)80109-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(00)80109-2

Key words

Navigation